Recent Insider Transactions - Apimeds Pharmaceuticals (NASDAQ: APUS)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ APUS Apimeds Pharmaceuticals

Kogan Elona / director

10/15/2025

Buy

$1.92

3,000

$6K

3,000

NASDAQ APUS Apimeds Pharmaceuticals

O'DONNELL CAROL A / director

10/15/2025

Buy

$1.92

3,000

$6K

3,000

NASDAQ APUS Apimeds Pharmaceuticals

Koo Jakap / director

10/15/2025

Buy

$1.92

3,000

$6K

3,000

NASDAQ APUS Apimeds Pharmaceuticals

Weintraub Bennett / director

10/15/2025

Buy

$1.92

3,000

$6K

3,000

NASDAQ APUS Apimeds Pharmaceuticals

Kim Christopher / director, officer: Chairman and CMO

10/15/2025

Buy

$1.92

3,000

$6K

3,000

NASDAQ APUS Apimeds Pharmaceuticals

Yoon Hankil / director

10/15/2025

Buy

$1.92

3,000

$6K

3,000

NASDAQ APUS Apimeds Pharmaceuticals

Emerson Erik C. / director, officer: Chief Executive Officer

10/15/2025

Buy

$1.92

215,000

$413K

215,000